Project Description
Updates from the CBTP Lab
The lab team at the Children’s Brain Tumor Project is working at an unprecedented pace in order to advance cures. Our team is focused on two strategic paths forward: (1) basic research toward breakthrough discoveries, and (2) translational research that will enable us to bring those discoveries to clinic.
Navigating the COVID-19 Pandemic
A message from our founders on the global health crisis and how it is impacting the Children's Brain Tumor Project.
JNS Pediatrics August 2021
Aug 17, 2021 - Designing new routes of administration for drugs to inoperable brain tumors is central to the mission of the Children’s Brain Tumor Project. A major advance forward in these efforts was recently published from Dr. Greenfield’s group in the August issue of Journal of Neurosurgery: Pediatrics.
Dr. Souweidane Presents at ASCO 2021
June 4, 2021 - Dr. Mark Souweidane, in partnership with Y-mAbs Therapeutics, presented interim phase 1 dose-escalation data for omburtamab for DIPG at virtual ASCO conference.
Charlie’s Story
Dec 23, 2020 - A patient of Dr. Mark Souweidane, Charlie tells the story of his diagnosis in his own words. We invite you to join us as we Light up the Lab in celebration of our heroes.
HayesTough Foundation Brings Hope to Children with CPC
Sept. 15, 2020 - A generous gift from the HayesTough Foundation will enable Dr. Mark Souweidane and his team take the final steps necessary toward launching the first-ever phase 1 clinical trial specifically designed for children with choroid plexus carcinoma.
New Peer-Reviewed Publication in ACTA Neuropatholgica Comms
JUNE 2020 - ACTA NEUROPATHOLOGICA COMMUNICATIONS features a peer-reviewed article authored by Dr. Jeffrey Greenfield.
Lack of Diversity in Brain Tumor Trials
June 19, 2020 - Research on missing diversity in brain tumor trials is reported on in the peer-reviewed publication, Neuro-oncology Advances.